Our Mission & VisionHistory of THETATHETA News ArchiveTHETA Staff & CommunityContact Us
Health Modelling and Health EconomicsClinical ResearchHealth Policy and Ethics
Current StudiesCompleted Studies
THETA Quarterly NewsletterReportsWorking PapersPublicationsPresentationsTHETA KT Day & Symposium
Health Technology Assessment InstituteTHETA RoundsHTA Courses
HTA OrganizationsHTA ConferencesHTA Resources & Tools
This is the "Home" page of the "Welcome to Toronto Health Economics and Technology Assessment Collaborative" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Welcome to Toronto Health Economics and Technology Assessment Collaborative  

Last Updated: Apr 22, 2014 URL: http://theta.utoronto.ca/home Print Guide RSS Updates

Home Print Page
  Search: 
 
 

.

  • THETA team
  • April 25, 2014
    Dr. Ahmed Bayoumi, MD, MSc, FRCPC: Supervised Injection Facilities in Toronto and Ottawa: Evidence, Models, and Policies
    Venue: Leslie Dan Pharmacy Building, 144 College Street, Room 255; Time: 1:00pm - 2:00pm
  • We are happy to announce the launch of SIESTAHome Sleep Study with ApneaDx™ for the Diagnosis and Management of
    Obstructive Sleep Apnea!

    Read more in News and Research Studies > Current Studies sections...
  • Dr. Pechlivanoglou teaches Pharmacoeconomics at
    Addis Ababa University, Ethiopia

    Please see News section below...
  • Please see all issues posted under
    Publications and Knowledge Translation section of THETA website
Image Slideshow Website by WOWSlider.com v3.4
 

RECENTLY PUBLISHED



Screening for HCV. - Wong WW, Krahn M
Publication Date: March 4, 2014
CMAJ. ;186(4):294.










Disease burden of chronic hepatitis B among Immigrants in Canada. - Wong W W L, Woo G, Heathcote JE, Krahn M.
Publication Date: March, 2013
Canadian Journal of Gastroenterology. 27(3):137-147

 

UPCOMING EVENTS

THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field. Recordings of some sessions are available in the THETA Rounds Archive.
 


Topic: Supervised Injection Facilities in Toronto and Ottawa: Evidence, Models, and Policies
Lecturer: Dr. Ahmed Bayoumi, MD, MSc, FRCPC
Date: Friday, April 25, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 255

 


PLEASE NOTE: this session has been rescheduled to April 11th and moved toRm # 255

Topic: Health care decision making in Mexico: The role of HTA and economic evaluation
Lecturer: Fernando Alarid, MS Economics, BSc Biomedical Engineering
Date: Friday, April 11, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 255

 


Topic: Evaluation of the Complex Interventions - THETA's experience  (Recording available)
Lecturer: Valeria E. Rac, MD, PhD
Date:
Friday,  March 7, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850



THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field.
 

Topic: Is society getting a good return on its funding investment in medical research? Examining the quality of reports of medical research and strategies to maximize the outputs of the investments
Lecturer: Dr. David Moher
Date:
Friday,  March 7, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850



 

THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field.
 

Topic: Prevention of cardiovascular disease – should we inform patients about reduced risk or increased longevity?
Lecturer: Ivar Kristiansen, PhD
Date:
Friday, Jan 31, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850

 


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.
 

Topic: The perilous promise of privacy: Health disclosures in a brave new world
Lecturer: Ester Moher, PhD
Date: Friday, Jan 17, 2014
Time: 1:00pm - 2:00pm
Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.

Topic: Mapping recent and current trends in pharmaceutical regulation: implications for innovation, safety and the cost-effective use of new medicines
Lecturer: Courtney Davis, PhD
Date: Friday, December 13, 2013
                               Time: 1:00pm - 2:00pm
                               Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.

Topic: From Papanicolaou to Papilloma: the corporatisation of cancer screening innovation
Lecturer: Stuart Hogarth, PhD
Date: Friday, Nov 29, 2013
Time: 1:00pm - 2:00pm
                              Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds
Topic: Adoption and cost effectiveness of breast cancer radiotherapy technologies: Quantitative and qualitative evaluation
Lecturer: Heather Taffet Gold, PhD
Date: Friday, Nov 8, 2013
Time: 1:00pm - 2:00pm
Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850

Pressure Ulcer Multi‐disciplinary Teams via Telemedicine (PUMTT) KT Seminar

Pressure Ulcer Prevention in Long Term Care Facilities Knowledge Exchange & Results Dissemination,

THETA Collaborative is organizing a KT Seminar with intention to:

  • To share research results from the PUMTT study – a project developed by THETA with the support of Health Quality Ontario, Canadian Patient Safety Institute, Community Care Access Centres – with healthcare partners in Long Term Care facilities
  • To exchange ideas for a future research agenda and collaboration with the Long Term Care facilities

Time: Monday, October 7, 2013, 1- 4pm

Venue: Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto

Webinar: Available upon request, please email Joanna Bielecki for invitation, at: joanna.bielecki@theta.utoronto.ca


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.
 
Sep 20, 2013:
An introduction to network meta-analysis (methods and applications) and why we should care about it.
Petros Pechlivanoglou, MSc, PhD, Research Associate at THETA

 

 

NEWS

Dr. Murray Krahn receives of 2014 Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment (HTA)

Sincere congratulations from the entire THETA team to our Program Director, Dr. Murray Krahn on receiving the prestigious Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment from CADTH and HTA community. Dr. Krahn received the award at 2014 CADTH Annual Meeting during an official Awards Luncheon ceremony.
Dr. Brian O’Rourke, President and CEO of CADTH stated “Dr. Murray Krahn has long been one of the brightest leaders in the field of HTA in Canada. This recognition is a testament to his exceptional contributions to the methodology of HTA, but also his dedication to nurturing and mentoring the next generation of scientists.”
The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes and celebrates individuals whose outstanding achievements have significantly advanced the field of health technology assessment, evidence-based drug reviews, or optimal technology utilization in Canada. Please read the official announcement at CADTH website.

   


Dr. Petros Pechlivanoglou teaches at School of Pharmacy, Addis-Ababa University, Ethiopia

In 2008, the University of Toronto and the Addis-Ababa University in Ethiopia formed the Toronto Addis Ababa Academic Collaboration (TAAAC) with the aim of building and strengthening capacity and sustainability in medical specialities and other health and non-health professional programs in Addis Ababa.  Under the leadership of Dr. Heather Boon, the Leslie Dan Faculty of Pharmacy has partnered with the School of Pharmacy at Addis Ababa University to establish a PhD program in Social Pharmacy at AAU. As part of this collaboration, the Leslie Dan Faculty of Pharmacy has committed to provide faculty members to teach graduate courses in Addis.  Most recently, Dr. Petros Pechlivanoglou, one of THETA's health economists taught a  graduate course in Pharmacoeconomics at the School of Pharmacy of Addis Ababa University. The course gave Ethiopian graduate pharmacy students the opportunity to familiarize themselves with the principles of economic evaluation of pharmaceutical products, technologies and services, as well as to implement these principles in healthcare decision problems. The experience was mutually rewarding as it gave Petros a better understanding of the peculiarities associated with conducting economic evaluations in low-income countries as well as it exposed him to the friendly, generous, hospitable and historically rich Ethiopian culture.

In addition to providing this graduate course, THETA will be hosting, from April on, one of the PhD students from the school of Pharmacy of Addis Ababa University. Mr. Eskinder Eshetu Ali will be visiting the Leslie Dan Faculty of Pharmacy for the next three  months to analyze the effects and costs of building capacity in mental health through the TAAAC program.

School of Pharmacy at Addis Ababa University

 


THETA's Health Technology Assessment Institute 2014

THETA together with the Department of Community Health and Epidemiology at Dalhousie University in collaboration with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and the CIHR-STIHR Health Care, Technology and Place Program will host the 2014 Health Technology Assessment Institute for Decision Makers.
The HTA Institute will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course will be useful to individuals who use HTA to make decisions relating to drugs, devices, and programs.

Date: July 14-16, 2014
Place: Dalhousie University
Registration date: April 15th.


THETA is happy to announce the launch of SIESTA!

SIESTA Home Sleep Study with ApneaDx™ for the Diagnosis and Management of Obstructive Sleep Apnea proposes to examine the validity, effectiveness, and cost-effectiveness of ApneaDx™, a new single-channel portable monitor designed to capture and analyze breath sounds to detect sleep apnea versus in-laboratory overnight sleep study with polysomnography – the gold standard for the diagnosis and management of obstructive sleep apnea.
SIESTA is both a multi-centre prospective validation study, as well as a pragmatic randomized single-blinded two armed non-inferiority trial. With a planned sample size of 330 participants, SIESTA will take approximately two years to complete. SIESTA is currently at the recruitment stage at the Kingston and Hamilton study sites. Dr. Mike Fitzpatrick is the lead Clinical Investigator at the Kingston Sleep Disorders Laboratory, with Nancy Myers as the onsite Study Coordinator. At the Hamilton Sleep Disorders Clinic, we have Dr. Ray Gottschalk as the Clinical Investigator and Jason Myers as the onsite Study Coordinator. REB submission is underway for our third site, Sleep & Apnea Assessment Unit in London Health Sciences Centre - Victoria Hospital with Dr. Charlie George.
ApneaDX™ is one of the first three companies selected by the MaRS Excellence in Clinical Innovation and Technology Evaluation (“EXCITE”) program.


Dr. Nicholas Mitsakakis organized a General Invited Session at the Annual Meeting of the Statistical Society of Canada (SSC).

This year University of Toronto is hosting the 2014 Annual Meeting of the Statistical Society of Canada (SSC) in May 25-28, 2014. THETA biostatistician Nicholas Mitsakakis, Assistant Professor, University of Toronto, and Eleanor Pullenayegum, Associate Professor, University of Toronto and  Scientist at the Hospital for Sick Children, organized a General Invited Session: Statistical Issues in Health Economics and Health Technology Assessment. The session will feature three prominent speakers:

Andy Willan, Professor, University of Toronto
Kristian Thorlund, Assistant Professor, McMaster University
Heejung Bang, Professor, University of California at Davis


THETA hosts HTA researchers from Norway

THETA has invited Professor Ivar Sønbø Kristiansen and his team to an all day workshop to explore common areas of research interest and avenues for future collaboration. Professor Kristiansen is a member of the Economic Evaluation of Health Technologies research group from the University of Oslo. Associate Professor Torbjørn Wisløff, also a member of University of Oslo research team, works for the Norwegian Knowledge Centre for the Health Services (NOKC). The meeting will take place at THETA offices on January 30th, 2014. Meeting Agenda.


Congratulations to Dr. Beate Sander...

Dr. Sander, THETA's investigator, is a new receipient of the three-year CIHR operating grant. Her grant titled “Estimating longitudinal healthcare costs for infectious diseases using administrative data” amounts to $474,627.
Co-PI: Jeff Kwong. Co-Investigators: Peter Austin, Natasha Crowcroft, Nick Daneman, Jordan Feld, Allison McGeer, Natasha Nanwa.


Dr. Pechlivanoglou's systematic review gets press exposure.

On September 6, 2013 Reuters Health (NEW YORK) released a news story commenting on the results of a published systematic review by Dr. Petros Pechlivanoglou: "Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review". After Dr. Pechlivanoglou email discussion with Reuters Health the story appeared in the NewsDaily - a service of the science news site ScienceDaily one of the Internet’s most popular science news web sites, and P4 Healthcare -  the online health care community that connects physicians, patients, pharmaceutical companies, and payers, with the leading specialty therapeutic practices.


THETA Staff present at this year's SMDM 2013 - 35th Annual Meeting of the Society for Medical Decision Making.

The theme: Bench, Bedside and Beyond: Medical Decision Making and Public Policy, October 19 - 23, 2013, Baltimore, MD

The Hepatitis C Drug Pipeline: Collaboration Between Academic and Hta Agency Partners to Develop an Early Economic Model. William W. L. Wong, Hong Anh Tu, Wendong Chen, Jordan J. Feld, Kristen Chelak,  Karen M. Lee, and Murray D. Krahn, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Impact of Increasing Wait Times on the Effectiveness of Transcatheter Aortic-Valve Replacement (Tavr) in High-Risk and Inoperable Patients with Severe Aortic Disease: a Discrete Event Simulation Model. Harindra C. Wijeysundera, William W. L. Wong, Maria C. Bennell, Stephen E. Fremes, Sam Radhakrishnan,  Mark Peterson,  and Dennis T. Ko The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Using Projections of Life Expectancy in Economic Decision Making P.Pechlivanoglou, M. Paulden, W.Wong, S. Bermingham , B. Pham, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Using Value of Information Methods When the Disease is Rare and the Treatment is Expensive – The Example of Hemophilia A. Lusine Abrahamyan, Andrew R. Willan, Joseph Beyene, Marjorie Mclimont, Victor Blanchette,  Brian M. Feldman for the Canadian Hemophilia Primary Prophylaxis (CHPS) Study Group. The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Poster Presentation.

Characteristics of Multi-disciplinary Heart Failure Clinics that Predict 1-year Cumulative Health Care Costs: A Population-based Study. Harindra C. Wijeysundera, Peter C. Austin, Xuesong Wang, Maria C. Bennell, Lusine Abrahamyan, Dennis T. Ko, Jack V. Tu, Murray Krahn. The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Cost-Effectiveness of Education and Activation, and a Rehabilitation Program, Compared to the Legislated Standard of Care for Acute Whiplash Injury in Ontario. Gabrielle van der Velde, DC, PhD1, Lusine Abrahamyan1, Pierre Coté2, Eleanor Boyle3, Heather Shearer, DC, FCCS(C), MSc2, Maja Stupar2, Craig Jacobs, DC, MSc, FCCS(C)2, Jeffrey Hoch4, Patrick Loisel5, Petros Pechlivanoglou, PhD1, David Cassidy3, and Andrew R. Willan, PhD7, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MA, U.S.A, Poster Presentation. (1)Toronto Health Economics & Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (2)UOIT-CMCC Centre for the Study of Disability Prevention and Rehabilitation, Toronto, ON, Canada, (3)University of Southern Denmark, Odense, Denmark, (4)Cancer Care Ontario, Toronto, ON, Canada, (5)University of Toronto, Toronto, ON, Canada, (6)SickKids Research Institute, Toronto, ON, Canada


 Personalized Medicine: Genomic Test for Breast Cancer Recurrence Found to be Cost Effective.

THETA press release - TORONTO, July 15,2013

The 6th Annual THETA Symposium and THETA KT Day

Both events gathered rave reviews from attendees. Many aspects were praised: select speakers, interesting topics, and choice of venue. Please check some presentations  posted under Publications and Knowledge Translation tab on THETA "Knowledge Translation to Policy" Day and Symposium page.


Dr. Murray Krahn delivered a winning “big idea for HTA” speech at the 2013 CADTH Symposium closing plenary.

Dr. Murray Krahn idea is early health technology assessment - bringing together scientists, payers, and innovators and using well-developed HTA methods to shorten timelines around the evaluation of new technologies.

The winning idea will be presented by Dr. Krahn at the next 2014 Symposium in a workshop format.

Please see Dr. Krahn’s speech at the closing plenary below.


THETA's Health Technology Assessment Institute 2013

The 2013 Health Technology Assessment Institute for Decision Makers will be held on JUNE 26-28, 2013. Please save the date.Registration is now open!


The 6th Annual THETA Symposium!

When: Thursday, May 30th, 2013

Where: Casa Loma, Toronto

This year’s theme will be “End-of-Life Care”, lead by Dr. Robert Fowler, Senior Scientist at Sunnybrook Research Institute. Please see the attached agenda for this meenting.

THETA KT Day

When: Wednesday, May 29th, 2013

Where: Casa Loma, Toronto

THETA would like to invite you to our fourth annual "Knowledge Translation to Policy" Day.

This year’s topic will focus on early health technology assessment (i.e. “Early HTA”). This new HTA research model is emerging, in which scientists, payers, and innovators work together early in the technology development process. This ensures that the clinical evidence will meet the needs of payers (e.g. Ministries of Health) and regulators (e.g. Health Canada) when it is brought to market, and is consonant with the needs of users.

We think it will be an interesting and interactive day, and look forward to seeing you there. Please see the attached agenda.


Dr. Krahn and other Department of Pharmacy researchers' excellence in education, research and program development linked to 11th best in the world ranking and top-ranking in Canada for the Department.

 

Read the full article: "Message from the Dean" in Pharmacy Alumni magazine here.

 

 

 


SAVE THE DATE: THETA's Health Technology Assessment Institute 2013

The 2013 Health Technology Assessment Institute for Decision Makers will be held on JUNE 26-28, 2013. Please save the date. Registration will open on March 15th.


THETA hosts international PRECIS Meeting - PRagmatic Explanatory Continuum Indicator Summaries - Pragmatic trial design tool

When: Monday, 11th March 2013, 9:30-4:30 p.m.

Where: Leslie Dan Pharmacy Building, University of Toronto

Host: Toronto Health Economics and Technology Assessment Collaborative (THETA). Please see the Agenda and a list of participants here.


PLEASE SAVE THE DATE - for the 6th Annual THETA Symposium!

When: Thursday, May 30th, 2013

Where: Casa Loma, Toronto

This year’s theme will be “End-of-Life Care”, lead by Dr. Robert Fowler, Senior Scientist at Sunnybrook Research Institute. Please see the attached flyer here – a detailed programme will be circulated in early spring.


Centre for the Evaluation of Technological Innovation gets funded through CFI New Initiatives Fund grant

Dr. Murray Krahn, the F. Norman Hughes Chair in Pharmacoeconomics at the Leslie Dan Faculty of Pharmacy, and Director of the Toronto Health Economics and Technology Assessment Collaborative (THETA), is the recent recipient of a five-year Canada Foundation for Innovation (CFI) New Initiatives Fund.

 

 

 


PLEASE SAVE THE DATE - THETA KT Day

What: The THETA Collaborative 4th Annual "Knowledge Translation to Policy" Day

When: Wednesday, May 29th, 2013

Where: Casa Loma, Toronto

THETA Collaborative is the Toronto Health Economics and Technology Assessment Collaborative. We are funded by the Ontario Ministry of Health and Long-Term Care to do policy relevant research, and support the work of Health Quality Ontario and the Ontario Health Technology Advisory Committee.

This year’s topic will focus on early health technology assessment (i.e. “Early HTA”). This new HTA research model is emerging, in which scientists, payers, and innovators work together early in the technology development process. This ensures that the clinical evidence will meet the needs of payers (e.g. Ministries of Health) and regulators (e.g. Health Canada) when it is brought to market, and is consonant with the needs of users.

As always, it will be an exciting day, and THETA really hopes to see you there. Please see the attached flyer here – a provisional agenda will follow shortly.


Ba' Pham presents his newest paper at the Canadian Association of Wound Care (CAWC) Conference in London, Ontario.

Presentation Topic: Great Canadian Bandaging Trial – Cost-effectiveness Analysis and Quality-of-life Results

Presenters: Ba’ Pham Conference, venue, location & time: CAWC Conference, London Convention Centre, London, Ontario.

Related articles:


THETA's Health Technology Assessment Institute in China

THETA in collaboration with the Institute of Health Policy, Management & Evaluation, Leslie Dan Faculty of Pharmacy, Health Care, Technology & Place Program at UofT and the China Health Development Research Center (CNHRC) hosted a session of the 2012 Health Technology Assessment Institute for Decision Makers in China last September 12-14.


Ba' Pham’s newest article published in BMC Health Services Research.

Title: Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging Trial Authors: Pham Ba', Margaret B Harrison, Chen H Maggie, Carley E Meg,


Professor Murray Krahn has been elected President of the Society for Medical Decision Making.

The SMDM is an international organization dedicated to improving health outcomes through the advancement of proactive systematic approaches to clinical decision making and policy-formation in healthcare by providing a scholarly forum that connects and educates researchers, providers, policy-makers, and the public. Society’s vision is that systematic proactive approaches should be used for decision making in health care, and SMDM is also promoting an integrated approach to health care decision making based on multiple perspectives and expertise from multiple disciplines. The Society's diverse membership includes trainees to senior researchers as well as educators, clinicians, managers, and policy makers, who represent a variety of backgrounds and academic disciplines. Congratulations, Dr. Krahn, on being elected to this noteworthy position. From: Pharmacopoeia, the newsletter for students, faculty and staff at the Leslie Dan Faculty of Pharmacy, University of Toronto, September 28, 2012.


Gabrielle van der Velde, DC, PhD, is a clinical epidemiologist at the THETA, teaches new Workshop at 7th IN-CAM Research Symposium

7th IN-CAM Research Symposium

DATE:Nov 2 - 4, 2012

LOCATION:University of Toronto, Leslie Dan Faculty of Pharmacy

We are very excited to announce a new addition to the Symposium program -

Workshop - INTRODUCTION TO ECONOMIC EVALUATIONS IN HEALTH CARE Sat. Nov 3rd, 2012 3:00-5:30pm

Led by: Gabrielle van der Velde DC, PhD, University of Toronto

Workshop description: There is growing interest in and need for health technology assessment and economic evaluation in the field of health care, given the twin realities of constrained health care budgets and rising health care costs. Consequently, health care policy makers are increasingly relying on economic evaluations to make decisions about health care in Canada. The purpose of this workshop is to introduce participants to cost-effectiveness analysis within the context of health care. Participants will be introduced to key concepts within the cost-effectiveness research framework, including elements of study design, methods, and analytical approaches. Participants will learn the meaning of statistics commonly used to assess the cost-effectiveness of health technologies, such as the incremental cost-effectiveness ratio (ICER) and net health benefit, as well as their interpretation. Other key concepts such as the cost-effectiveness plane, confidence ellipses, and willingness-to-pay threshold will also be introduced. The workshop will conclude with a group exercise that will consist of reading, reviewing, and critically appraising a cost-effectiveness analysis of a complementary-alternative intervention published in a peer-reviewed journal.

About the presenter: Gabrielle van der Velde, D.C., Ph.D., is a clinical epidemiologist at the Toronto Health Economics and Technology Assessment (THETA) Collaborative, an Assistant Professor in the Leslie Dan Faculty of Pharmacy (University of Toronto), and an Adjunct Scientist at the Institute for Work & Health. A licensed chiropractor trained at the Canadian Memorial Chiropractic College, she practiced for 8 years before completing a Ph.D. in Clinical Epidemiology and Health Care Research with a focus on applied health economics and health technology assessment, at the University of Toronto. She is currently a member of the Core Scientific Team and Guideline Expert Panel developing the first evidence-based ‘Clinical Practice Guideline for the Management of Minor Injuries after Traffic Collisions’ for the government of Ontario. She is the principal investigator of an economic evaluation alongside the University Health Network Whiplash Intervention Trial which will determine the cost-effectiveness of two rehabilitation programs compared to the current legislated standard of care for whiplash in Ontario.

For more information about the Symposium workshops or the overall program, go to: Symposium Program


THETA's Health Technology Assessment Institute is Going to China

THETA in collaboration with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and Health Care, Technology and Place Program will host another session of the 2012 Health Technology Assessment Institute for Decision Makers in China on September 12-14.

The HTA Institute will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course will be useful to individuals who use HTA to make decisions relating to drugs, devices, and programs


THETA Collaborator Publishes Paper on Utilities and Hep B

THETA Collaborator Gloria Woo has published a paper entitled "Health state utilities and quality of life in patients with hepatitis B" in the July 2012 issue of the Canadian Journal of Gastroenterology. (Volume 26 Issue 7, pages 445-451)


Mike Paulden Wins ISPOR Best Podium Research Presentation

THETA's Mike Paulden has won the ISPOR Best Podium Research Presentation Award for his talk entitled Advancing the methods of cost-effectiveness analysis: Why it's time to move on from ICERs and thresholds. This is the second year in a row that Mr. Paulden has won this award.


THETA Newsletter - Summer 2012

The THETA Summer Newsletter is out for 2012.

THETA Symposium 2012 Presentations The presentations from the THETA Symposium 2012 are now available.


Evolutions in Network Meta-Analysis

Methods are quickly evolving which enable estimates of efficacy of multiple treatments simultaneously or estimates of efficacy in the absence of trials between treatments. At the same time, the Canadian Agency for Drugs and Technology in Health (CADTH) has identified that in estimates of clinical benefit, meta-analysis methods are sometimes not used when they should be, incorrectly done, or not fully and transparently reported.

At this workshop experts will review indirect and mixed treatment comparison approaches to evidence synthesis, how mixed treatment comparison meta-analysis is evolving in Canada, and the status of the development of Canadian guidelines for good research practices for indirect treatment comparisons.


THETA at CADTH

THETA is Presenting at CADTH 2012.


Video of Personalized Medicine Talk

THETA Staff member Mike Paulden delivered a talk at the Personalized Medicine Workshop in Ottawa. Here is a video of that talk.


Discounting Paper in Print in Health Economics

THETA member Mike Paulden's paper Budget allocation and the revealed social rate of time preference for health is in print in Health Economics.


THETA Investigator in the News

THETA Investigator Wendong Chen has been in the news related to his recent paper Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma:


THETA Investigator Funded by CPAC

THETA Investigator Wendong Chen has had his proposal, "Comparing microsimulation model versus Markov model in assessing the cost-effectiveness of low-dose computed tomography for lung cancer screening in heavy smokers" accepted by the Canadian Partnership Against Cancer (CPAC).


Modelling Methods for Health Economic Evaluation

This modeling short course is to be held in collaboration with the Hospital Authority Hong Kong, and will be based at the Hospital Authority Building in Hong Kong.

The short course will provide a day on introductory modelling methods and then proceed to intermediate and advanced topics on days 2 and 3. It will include teaching materials which have been used over the last 10 years in courses run by the Universities of York and Glasgow in the UK, and McMaster University in Canada.


AHRC Symposium 2012 - Call for Abstracts

AHRC's Symposium on Comparative Effectiveness Research Methods has put out a call for abstracts. Visit the website to find out how to present your work at AHRC.


Article in the Journal of Viral Hepatitis

THETA Investigator Wendong Chen is lead author on a new article in the Article in the Journal of Viral Hepatitis entitled Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma.


CADTH Symposium Program Released

The preliminary program for the CADTH Symposium (April 15-17 in Ottawa) has been released. The Symposium features contributions from several THETA Investigators and Collaborators, as well as presentations of several THETA projects.


Priorities Conference 2012

Priorities 2012 is the biennial conference of the International Society on Priorities in Health Care (ISPHC). The 10th International Conference will be held in Vancouver, British Columbia, at the Westin Bayshore, September 16 - 19, 2012.



Back to Top

  • OUR PARTNERS
  • Health Quality Ontario
  • Cancer Care Ontario
  • Leslie Dan Faculty of Pharmacy at the University of Toronto
  • Toronto General Hospital
Description

Loading  Loading...

Tip